ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/12/2023
Back to search
Official data from USPTO
REIMAGINE CARE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
REIMAGINE CARE
ST13
US500000097003850Class
35, 42, 44, 45
Filing
97003850
Registration
7020321
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
07/12/2023
Trademark type
Word
Nice classes
35, 42, 44, 45
Filing date
08/31/2021
Registration date
04/04/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/04/2023
Last transaction
04/04/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/10/2020
First use in commerce
08/10/2020
Drawing code
4
Owner type
03
Owner location
NASHVILLE, TN
Examiner
STIGLITZ, SUSAN
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
REIMAGINE CARE, INC.
The Martin Companies, LLC
Representatives
Benjamin W. Janke Baker, Donelson, Bearman, Caldwell & Berkowitz, A
Technical classification
Nice Classes
Class 35Class 42Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting and management in the field of clinical trialsproviding information management services in partnership with pharmaceutical companies and clinical research organizations (CROs) to administer and monitor oncology clinical trials at patients' homescontract clinical trials into value-based care contracts and provide clinical trial access to diverse patient populations for clinical trial participationaccelerate trial completionlower trial costs
Class 42
Platform as a service (PAAS) featuring computer software platforms for providing oncology hospital at home technology-enabled services in the nature of monitoring medication administration and dosageassessing and reporting on pain levels for supporting oncologists and other healthcare providers in delivering high-qualitylower-costpatient-centric cancer care; conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of cancer diagnosis and treatmentpartnering with pharmaceutical companies and clinical research organizations (CROs) to administer and monitor oncology clinical trials at patients' homescontract clinical trials into value-based care contracts and provide clinical trial access to diverse patient populations for clinical trial participationaccelerate trial completionlower trial costs; Platform as a service (PAAS) featuring computer software platforms for monitoringanalyzingassessingtransmitting patient medical and healthcare data to inform cancer care delivery optimization to patients and cancer care providers through a value-based care logistics management platform to efficiently and effectively manage workforce staffingpatient carepharmaceutical supplies required in alternative cancer delivery models; Platform as a service (PAAS) featuring computer software platforms for providing a comprehensive oncology clinical management solutionmedication administration and managementsupportive carelab testingpain managementday-after-chemo injection of colony-stimulating factor drugsadvanced care planningat-home palliative care; Platform as a service (PAAS) featuring computer software platforms for providing cancer patients extensive cancer care navigation services in the nature of providing coordinated care by assessingtriagingfollow-up and supporting patients 24/7 and on-demandfor keeping patients with compromised immune function out of institutional settings and treating them in the convenience of their homes
Class 44
Analysis of oncology medical information for the treatment of cancer in the home on behalf of patients and cancer care providersincluding analysis of value-based carecare coordinationdecision-making servicesinsightsas well as the evaluation of oncology clinical research studies for patient access and participation in clinical trials; medical services in the field of oncologyproviding oncology infusion therapy and oral oncolytic in alternative settings; medical servicesproviding real-time symptom management and telemedicine triage via a dedicated multi-disciplinary oncology care team to optimize adverse cancer patient events and reactions to cancer
Class 45
Providing personal support services for patients and families of patients undergoing cancer treatmentemotional counseling and emotional support through volunteers in the community who include cancer survivorsas well as family members and friends of cancer patients
Publications
History of USPTO decisions and trademark events.
26 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/04/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
04/04/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/25/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/24/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/30/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/30/2023
IUAF
USE AMENDMENT FILED
12/30/2022
EISU
TEAS STATEMENT OF USE RECEIVED
12/30/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/04/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/09/2022
PUBO
PUBLISHED FOR OPPOSITION
08/09/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/20/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/06/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/22/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/22/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/22/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/07/2022
GNRT
NON-FINAL ACTION E-MAILED
06/07/2022
CNRT
NON-FINAL ACTION WRITTEN
06/07/2022
DOCK
ASSIGNED TO EXAMINER
06/06/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/04/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/04/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/04/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/14/2021
NWAP
NEW APPLICATION ENTERED
09/03/2021
Continuous trademark protection
Get notified about every new filing that threatens REIMAGINE CARE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.